Harrison Donna, Buskmiller Cara, Chireau Monique, Ruppersberger Lester A, Yeung Patrick P
American Association of Pro-Life Obstetricians and Gynecologists, Eau Claire, MI, USA.
Saint Louis University, Saint Louis, MO, USA.
Linacre Q. 2018 Nov;85(4):453-469. doi: 10.1177/0024363918815611. Epub 2019 Jan 3.
The purpose of this review was to determine whether there is evidence that ovulation can occur in women using hormonal contraceptives and whether these drugs might inhibit implantation. We performed a systematic review of the published English-language literature from 1990 to the present which included studies on the hormonal milieu following egg release in women using any hormonal contraceptive method. High circulating estrogens and progestins in the follicular phase appear to induce dysfunctional ovulation, where follicular rupture occurs but is followed by low or absent corpus luteum production of progesterone. Hoogland scoring of ovulatory activity may inadvertently obscure the reality of ovum release by limiting the term "ovulation" to those instances where follicular rupture is followed by production of a threshold level of luteal progesterone, sufficient to sustain fertilization, implantation, and the end point of a positive β-human chorionic gonadotropin. However, follicular ruptures and egg release with subsequent low progesterone output have been documented in women using hormonal contraception. In the absence of specific ovulation and fertilization markers, follicular rupture should be considered the best marker for egg release and potential fertilization. Women using hormonal contraceptives may produce more eggs than previously described by established criteria; moreover, suboptimal luteal progesterone production may be more likely than previously acknowledged, which may contribute to embryo loss. This information should be included in informed consent for women who are considering the use of hormonal contraception.
For this study, the authors looked at English-language research articles that focused on how hormonal birth control, such as the birth control pill, may affect very early human embryos. The authors found that abnormal ovulation, or release of an egg followed by abnormal hormone levels, may often occur in women using hormonal birth control. This may increase the number of very early human embryos who are lost before a pregnancy test becomes positive. For women who are thinking about using hormonal birth control, this is important information to consider.
本综述的目的是确定是否有证据表明使用激素避孕的女性会排卵,以及这些药物是否会抑制着床。我们对1990年至今已发表的英文文献进行了系统综述,其中包括对使用任何激素避孕方法的女性排卵后激素环境的研究。卵泡期高循环雌激素和孕激素似乎会诱导功能失调性排卵,即卵泡破裂但随后黄体产生的孕酮水平低或缺乏。排卵活性的胡格兰评分可能会无意中掩盖卵子释放的实际情况,因为它将“排卵”一词仅限于卵泡破裂后产生阈值水平的黄体孕酮的情况,这种水平足以维持受精、着床以及β-人绒毛膜促性腺激素阳性的终点。然而,使用激素避孕的女性中已记录到卵泡破裂和卵子释放,随后孕酮产量低。在没有特定排卵和受精标志物的情况下,卵泡破裂应被视为卵子释放和潜在受精的最佳标志物。使用激素避孕的女性可能比既定标准所描述的产生更多卵子;此外,黄体孕酮产生不理想的可能性可能比之前认识到的更大,这可能导致胚胎丢失。这些信息应纳入考虑使用激素避孕的女性的知情同意书中。
在本研究中,作者查看了聚焦于激素避孕药(如避孕药丸)如何影响人类早期胚胎的英文研究文章。作者发现,使用激素避孕药的女性常出现异常排卵,即卵子释放后激素水平异常。这可能会增加在妊娠试验呈阳性之前丢失的人类早期胚胎数量。对于考虑使用激素避孕药的女性来说,这是重要的参考信息。